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VISA strains), with no totally vancomycin-resistant (VRSA) strains.
All of phenotypic MRSA isolates, except of one, were positive for
PBP2a.
Conclusion: The study concludes that S. aureus is the most
prevalent pathogen causing bacteremia in leukemia patients, with
MRSA variety comprising the majority of these strains. Also, phe-
notypic method for MRSA detection can be performed using either
ofMethicillin, Oxacillin, or Cefoxitin with same results, with a non-
signiﬁcant statistical difference between the phenotypic method
and the genotypic method- via the PBP2a detection.
http://dx.doi.org/10.1016/j.ijid.2016.02.224
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Background: VancomycinResistant Enterococci (VRE) emerged
as one of the major nosocomial pathogen across the globe. Gut
colonisation rate with VRE is higher in patients admitted to ICUs
due to high antibiotic pressure. VRE colonisation increases the risk
of developing infection up to 5-10 folds. The aim of this study was
to determine the rates of VRE colonization among patients admit-
ted in two of the ICUs i.e. Medical Intensive Care Unit (MICU) and
Pediatric Intensive Care Unit (PICU) and to assess the various risk
factors which are associated with VRE colonization.
Methods & Materials: Rectal swabs were collected after
48hours of ICU admission from a total of 302 and 198 patients
from MICU and PICU respectively. Additionally samples were col-
lected every 48hours from 32 patients admitted in MICU and 19
patients in PICU whose initial VRE colonization was negative. The
samples were inoculated on to Bile Esculin Sodium azide Agar
(BEA) with 6mg/ml of vancomycin. Growth on this medium were
identiﬁed by standard biochemical test and Minimum Inhibitory
Concentration (MIC) of vancomycin and teicoplanin was detected
by Agar dilution method. Resistance genes for vancomycin were
detected by PCR. Risk factors were assessed by logistic regression
analysis. The patients were followed up to determine VRE infection
rates
Results: The rates of VRE colonization in patients admitted
to MICU was signiﬁcantly higher (29%) than those in PICU (19%).
Majority of the isolates were Enterococcus faecalis (62.6%) followed
by Enterococcus faecium (38.4%). All the VRE isolates were positive
for vanA gene. Younger age, increased duration of hospital stay,
consumption of ceftriaxone and vancomycin were found to be sig-
niﬁcantly associated with VRE colonization in MICU, while in PICU,
only vancomycin usage was the signiﬁcant risk factor. Among VRE
colonized patients, six (4.7%) acquired VRE infection.
Conclusion: The VRE colonization rates in our ICUs were com-
parable to other hospitals worldwide. Strict adherence to hand
hygiene and education of health care workers is necessary to min-
imize the nosocomial transmission of this organism.
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Background: As the use of colistin to treat carbapenem resis-
tant gram negative infections increases, colistin resistance is being
increasingly reported in Indian hospitals.
Methods & Materials: Retrospective chart review of clinical
data from patients with colistin resistant isolates (MIC>2). Clin-
ical proﬁle, outcome and antibiotic combinations that were used to
treat colistin resistant infection were analysed.
Results: Twenty four colistin resistant isolates were reported
over 18months (Jan 2014–June 2015). Themean age of the patients
was 58.33; average length of stay was 36.37 days. Previous hos-
pitalisation within 3 months was noted in all 24 patients. An
invasive device was used in 22(91.67%) patients. Urine was the
commonest site of infection=8(33%), followed by blood= 6(25%),
respiratory=5(20.8%), pus=4(16.67%) and other (CSF)=1(4.17%).
Commonest organism was Klebsiella, n =21(87.5%). Antibiotics
that were used in their current admission prior to isolating a
colistin resistant organismwere: colistin in 15 patients(62.5%), car-
bapenem in 19(79.17%), BL-BLI in 9(37.5%), tigecycline in 12(50%).
16(66.6%) were considered to have true infection while 8 (33.3%)
were considered as colonisation andwerenot treated. Sensitivity of
these isolates to other drugs tested were – tigecycline 18/24(75%),
chloramphenicol 15/24(62.5%), amikacin 7/24(29.17%), cotrimox-
azole 3/24(12.5%). Fosfomycin was tested in 4 isolates only and
was sensitive in all. Antibiotic that were used for treatment
were combinations of tigecycline, chloramphenicol, fosfomycin,
amikacin, ciproﬂoxacin, cotrimoxazole and sulbactam. Among 16
patients with true infection, 4(25%) improved, 9(56.25%) expired
and 3(18.75%) were transferred to other centers in poor condition
at patient’s request. Among 8 patients who were considered to
have colonisation, there were no deaths and 7(87.5%) improved.
Among the 6 bacteremic cases, 5 patients expired and 1 improved.
Among the non-bacteremic patientswith true infections 4/10(40%)
expired. Bacteremic patients had a signiﬁcantly higher risk of death
compared to all non-bacteremic patients (p =0.014) though not
signiﬁcantly in non-bacteremic infections after exclusion of col-
onization (p=0.145).
Conclusion: Colistin resistance among Gram negative bacteria,
especially Klebsiella, is emerging in Indian hospitals and carries a
